We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$66.4B
AUM Growth
+$5.93B
(+9.8%)
Cap. Flow
-$619M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
13.02%
Holding
3,510
New
779
Increased
864
Reduced
1,015
Closed
774
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$500M |
| 2 |
Arista Networks
ANET
|
+$316M |
| 3 |
Union Pacific
UNP
|
+$271M |
| 4 |
Eli Lilly
LLY
|
+$271M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$495M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$388M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$369M |
| 5 |
Mastercard
MA
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Consumer Discretionary | 9.99% |
| 3 | Financials | 9.73% |
| 4 | Industrials | 7.81% |
| 5 | Healthcare | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Citizens Financial Group
CFG
$30.6B
| $71.3M | 0.11% |
+1,592,787
| New | +$62.7M |
|
227
BridgeBio Pharma
BBIO
$16.5B
| $70.9M | 0.11% |
1,641,620
+841,545
| +105% | +$30.6M |
|
|
EA
228
DELISTED
Electronic Arts
EA
| $70.4M | 0.11% |
440,704
+420,894
| +2,125% | +$62.2M |
|
229
Broadstone Net Lease
BNL
$4.02B
| $69.6M | 0.1% |
4,335,166
+2,951,207
| +213% | +$47.3M |
|
230
General Motors
GM
$76.8B
| $69.6M | 0.1% |
1,413,344
+1,067,506
| +309% | +$50.6M |
|
231
Pentair
PNR
$11B
| $69.3M | 0.1% |
674,715
+77,524
| +13% | +$7.24M |
|
232
PG&E
PCG
$38.5B
| $67.9M | 0.1% |
4,869,483
+1,842,361
| +61% | +$30M |
|
233
Williams-Sonoma
WSM
$29.6B
| $67.3M | 0.1% |
412,076
+188,351
| +84% | +$29.6M |
|
234
CALL
Bank of America
BAC
$442B
| $67.1M | 0.1% |
1,417,000
+938,800
| +196% | +$39.5M |
|
235
TE Connectivity
TEL
$62.6B
| $66.8M | 0.1% |
396,068
+27,090
| +7% | +$4.11M |
|
236
Humana
HUM
$46.2B
| $66.5M | 0.1% |
272,025
+208,086
| +325% | +$51.9M |
|
237
Vistra
VST
$47.4B
| $66.4M | 0.1% |
342,677
+314,069
| +1,098% | +$46.5M |
|
238
Tenaris
TS
$26.8B
| $66.1M | 0.1% |
1,767,924
+53,155
| +3% | +$1.82M |
|
239
Charles River Laboratories
CRL
$12.8B
| $65.9M | 0.1% |
434,226
+381,432
| +722% | +$50.9M |
|
240
Americold
COLD
$4.27B
| $65.9M | 0.1% |
3,961,222
-616,177
| -13% | -$11.2M |
|
241
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
| $65.6M | 0.1% |
810,500
-265,100
| -25% | -$21.5M |
|
242
PUT
Rivian
RIVN
$23.2B
| $65.5M | 0.1% |
4,770,600
-312,100
| -6% | -$4.23M |
|
243
DraftKings
DKNG
$11.9B
| $65.3M | 0.1% |
+1,523,345
| New | +$54.6M |
|
|
BPMC
244
DELISTED
Blueprint Medicines
BPMC
| $64.9M | 0.1% |
505,957
+445,675
| +739% | +$46.3M |
|
245
CALL
Core Scientific
CORZ
$6.75B
| $64.8M | 0.1% |
3,796,200
+1,820,200
| +92% | +$18.2M |
|
246
PUT
Intuit
INTU
$89B
| $64.7M | 0.1% |
82,100
+47,300
| +136% | +$32M |
|
247
Ferguson
FERG
$49.8B
| $64.5M | 0.1% |
296,411
+259,063
| +694% | +$47.7M |
|
248
PUT
ARK Innovation ETF
ARKK
$6.29B
| $64.3M | 0.1% |
915,100
+621,200
| +211% | +$34.2M |
|
249
Vertiv
VRT
$105B
| $64.3M | 0.1% |
500,698
+372,735
| +291% | +$36.2M |
|
250
Universal Health Services
UHS
$10.5B
| $64M | 0.1% |
353,441
+211,834
| +150% | +$38.2M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Balyasny Asset Management held 3,510 positions worth $66.4B, up 9.8% from $60.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Balyasny Asset Management's Q2 2025 filing shows 779 new, 864 increased, 1,015 reduced and 774 closed positions. Its largest new stake was Arista Networks: 3,646,977 shares worth $373M. The largest sale was iShares Core S&P 500 ETF, an estimated $495M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Financials.
- Balyasny Asset Management's largest Q2 2025 buy was Arista Networks: 3,646,977 shares worth $373M.
- Balyasny Asset Management added most to Brown & Brown in Q2 2025, an estimated $500M increase.
- Balyasny Asset Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $495M.
- Balyasny Asset Management fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2025, selling an estimated $369M.
- Balyasny Asset Management's ten largest holdings make up 13% of its $66.4B portfolio in Q2 2025.
- Balyasny Asset Management opened 779 new positions and closed 774 in Q2 2025.
- Balyasny Asset Management's portfolio value rose 9.8% quarter-over-quarter to $66.4B.
Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.